Literature DB >> 21864623

The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.

Beza Seyoum1, Masahide Yano, Liise-anne Pirofski.   

Abstract

Bacteremic pneumonia with some pneumococcal capsular serotypes, including serotype 3 (ST3), has been associated with a higher risk of death, whereas others, such as ST8, are associated with a lower risk. To provide a molecular basis for understanding such differences, we used oligo cDNA microarrays to analyze and compare the gene expression profiles of the lungs of Balb/c mice infected intranasally with either ST3, strain A66.1, or ST8, strain ATCC 6308 (6308). Compared to uninfected controls, infection with either A66.1 or 6308 led to inoculum-dependent expression of IFN-γ inducible CXC chemokines among other pro-inflammatory genes. To investigate the role that IFN-γ inducible chemokines CXCL9, CXCL10 and CXCL11 play in A66.1- and 6308-induced pneumonia, we examined the effect of the absence of their common receptor, CXCR3, on intranasal infection in CXCR3(-/-) (Balb/c) mice. Compared to wild type (WT) mice, virulence of A66.1 but not 6308 was attenuated in CXCR3(-/-) mice. A66.1-infected CXCR3(-/-) mice had fewer lung neutrophils and more alveolar macrophages 48 h after infection and fewer blood CFU 72 h after infection. Histopathological examination of lung sections revealed less inflammation among A66.1-infected CXCR3(-/-) than WT mice. The reduced virulence of A66.1 in CXCR3(-/-) mice suggests that inhibition of the functional activity of IFN-γ inducible chemokines modulates the host response to A66.1, in turn suggesting a novel approach to improve vaccine-mediated protection against ST3 pneumonia.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864623      PMCID: PMC3191269          DOI: 10.1016/j.vaccine.2011.08.064

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  48 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

Review 2.  Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers.

Authors:  U K Buchwald; L Pirofski
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

3.  Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

Authors:  F Dallaire; N Ouellet; Y Bergeron; V Turmel; M C Gauthier; M Simard; M G Bergeron
Journal:  J Infect Dis       Date:  2001-06-26       Impact factor: 5.226

4.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

5.  Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.

Authors:  Sylvia Knapp; Jaklien C Leemans; Sandrine Florquin; Judith Branger; Nico A Maris; Jennie Pater; Nico van Rooijen; Tom van der Poll
Journal:  Am J Respir Crit Care Med       Date:  2002-09-25       Impact factor: 21.405

6.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

7.  Six newly recognized types of Streptococcus pneumoniae.

Authors:  J Henrichsen
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients.

Authors:  J C Sanz; E Cercenado; M Marín; B Ramos; C Ardanuy; I Rodríguez-Avial; E Bouza
Journal:  Clin Microbiol Infect       Date:  2011-04-05       Impact factor: 8.067

9.  Effectiveness of pneumococcal polysaccharide vaccine in older adults.

Authors:  Lisa A Jackson; Kathleen M Neuzil; Onchee Yu; Patti Benson; William E Barlow; Annette L Adams; Christi A Hanson; Lisa D Mahoney; David K Shay; William W Thompson
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

10.  Requirement of the chemokine receptor CXCR3 for acute allograft rejection.

Authors:  W W Hancock; B Lu; W Gao; V Csizmadia; K Faia; J A King; S T Smiley; M Ling; N P Gerard; C Gerard
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  11 in total

1.  A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.

Authors:  Sarah Weber; Haijun Tian; Nico van Rooijen; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

2.  Contribution of Puma to Inflammatory Resolution During Early Pneumococcal Pneumonia.

Authors:  Daniel E Kennedy Ii; Perceus Mody; Jean-Francois Gout; Wei Tan; Keun Seok Seo; Alicia K Olivier; Jason W Rosch; Justin A Thornton
Journal:  Front Cell Infect Microbiol       Date:  2022-05-26       Impact factor: 6.073

3.  An ahemolytic pneumolysin of Streptococcus pneumoniae manipulates human innate and CD4⁺ T-cell responses and reduces resistance to colonization in mice in a serotype-independent manner.

Authors:  M Nadeem Khan; John Robert Coleman; Joshua Vernatter; Avanish Kumar Varshney; Chad Dufaud; Liise-Anne Pirofski
Journal:  J Infect Dis       Date:  2014-06-13       Impact factor: 5.226

4.  Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.

Authors:  Kimberly A Hofmeyer; Lisa Scandiuzzi; Kaya Ghosh; Liise-Anne Pirofski; Xingxing Zang
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422

5.  Draft Genome Sequence of the Streptococcus pneumoniae Avery Strain A66.

Authors:  Christoph Hahn; Ewan M Harrison; Julian Parkhill; Mark A Holmes; Gavin K Paterson
Journal:  Genome Announc       Date:  2015-06-25

6.  The role of CXCL10 in the pathogenesis of experimental septic shock.

Authors:  Daniela S Herzig; Liming Luan; Julia K Bohannon; Tracy E Toliver-Kinsky; Yin Guo; Edward R Sherwood
Journal:  Crit Care       Date:  2014-06-02       Impact factor: 9.097

7.  Variation in Inflammatory Response during Pneumococcal Infection Is Influenced by Host-Pathogen Interactions but Associated with Animal Survival.

Authors:  Magda S Jonczyk; Laura Escudero; Nicolas Sylvius; Martin Norman; Birgitta Henriques-Normark; Peter W Andrew
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

8.  Peptidoglycan Recognition Protein 3 Does Not Alter the Outcome of Pneumococcal Pneumonia in Mice.

Authors:  Anshu Shrivastav; Alexander N Dabrowski; Claudia Conrad; Nelli Baal; Holger Hackstein; Stephanie Plog; Kristina Dietert; Achim D Gruber; Philippe D N'Guessan; Sahar Aly; Norbert Suttorp; Janine Zahlten
Journal:  Front Microbiol       Date:  2018-02-01       Impact factor: 5.640

9.  Absence of Streptococcus pneumoniae Capsule Increases Bacterial Binding, Persistence, and Inflammation in Corneal Infection.

Authors:  Mary A Carr; Dennis Marcelo; K Michael Lovell; Angela H Benton; Nathan A Tullos; Erin W Norcross; Brandon Myers; Marcus K Robbins; Hayley Craddieth; Mary E Marquart
Journal:  Microorganisms       Date:  2022-03-25

10.  Inflammation induced by influenza virus impairs human innate immune control of pneumococcus.

Authors:  Simon P Jochems; Fernando Marcon; Beatriz F Carniel; Mark Holloway; Elena Mitsi; Emma Smith; Jenna F Gritzfeld; Carla Solórzano; Jesús Reiné; Sherin Pojar; Elissavet Nikolaou; Esther L German; Angie Hyder-Wright; Helen Hill; Caz Hales; Wouter A A de Steenhuijsen Piters; Debby Bogaert; Hugh Adler; Seher Zaidi; Victoria Connor; Stephen B Gordon; Jamie Rylance; Helder I Nakaya; Daniela M Ferreira
Journal:  Nat Immunol       Date:  2018-10-29       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.